| Name | CDK4/6-IN-4 |
|---|
| Description | CDK4/6-IN-4, the active metabolite of Abemaciclib, is a selective CDK4/6 inhibitor for the treatment of cancer[1]. |
|---|---|
| Related Catalog | |
| Target |
CDK4 CDK6 |
| References |
| Molecular Formula | C27H32F2N8O |
|---|---|
| Molecular Weight | 522.59 |